These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8133793

  • 21. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women.
    Dansuk R, Unal O, Karageyim Y, Esim E, Turan C.
    Gynecol Endocrinol; 2004 May; 18(5):233-9. PubMed ID: 15346658
    [Abstract] [Full Text] [Related]

  • 22. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M, van der Mooren MJ, Mijatovic V, Bouman AA, Schijf CP, Kroeks MV, Franke HR, Kenemans P.
    Menopause; 2003 May; 10(6):550-8. PubMed ID: 14627865
    [Abstract] [Full Text] [Related]

  • 23. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C, Nyberg P, Nordström L, Samsioe G.
    Maturitas; 2002 May 20; 42(1):55-62. PubMed ID: 12020980
    [Abstract] [Full Text] [Related]

  • 24. Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women.
    Słowińska-Srzednicka J, Zgliczyński S, Chotkowska E, Srzednicki M, Stopińska-Głuszak U, Jeske W, Brzezińska A, Zgliczyński W, Sadowski Z.
    J Intern Med; 1993 Nov 20; 234(5):447-51. PubMed ID: 7693846
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
    Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM.
    N Engl J Med; 1991 Oct 24; 325(17):1196-204. PubMed ID: 1922206
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T.
    Circulation; 2002 Oct 01; 106(14):1771-6. PubMed ID: 12356628
    [Abstract] [Full Text] [Related]

  • 33. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
    Raudaskoski TH, Tomás EI, Paakkari IA, Kauppila AJ, Laatikainen TJ.
    Maturitas; 1995 Jun 01; 22(1):47-53. PubMed ID: 7666816
    [Abstract] [Full Text] [Related]

  • 34. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M, Kahri J, Pyörälä T, Puolakka J, Luotola H, Lappi M, Lahdenperä S, Taskinen MR.
    Atherosclerosis; 1997 Mar 21; 129(2):249-59. PubMed ID: 9105568
    [Abstract] [Full Text] [Related]

  • 35. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Mar 21; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 36. [Serum lipids in treatment with transdermal estradiol and oral norethisterone acetate].
    Mück AO, Salbach B, Rabe T, von Holst T, Runnebaum B.
    Geburtshilfe Frauenheilkd; 1995 Jul 21; 55(7):393-9. PubMed ID: 7557206
    [Abstract] [Full Text] [Related]

  • 37. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH.
    Arch Intern Med; 1995 Jul 21; 156(15):1693-700. PubMed ID: 8694668
    [Abstract] [Full Text] [Related]

  • 38. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
    Schram JH, Boerrigter PJ, The TY.
    Maturitas; 1995 Sep 21; 22(2):121-30. PubMed ID: 8538480
    [Abstract] [Full Text] [Related]

  • 39. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR, Puolakka J, Pyörälä T, Luotola H, Bjäörn M, Kääriänen J, Lahdenperä S, Ehnholm C.
    Arterioscler Thromb Vasc Biol; 1996 Oct 21; 16(10):1215-21. PubMed ID: 8857916
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the impact of oral versus transdermal estrogen on serum lipoproteins.
    Erenus M, Kutlay K, Kutlay L, Pekin S.
    Fertil Steril; 1994 Feb 21; 61(2):300-2. PubMed ID: 8299786
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.